Koji Matsuo

← Back to University of Southern California

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

1. Paraneoplastic Thrombocytosis in Ovarian Cancer

   2012 · 800 citations

2. Regulation of Tumor Angiogenesis by EZH2

   2010 · 399 citations

3. Validation of the 2018 FIGO cervical cancer staging system

   2018 · 323 citations

4. Sustained Small Interfering RNA Delivery by Mesoporous Silicon Particles

   2010 · 316 citations

5. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines

   2019 · 293 citations

6. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States

   2021 · 213 citations

7. Clinical impact of selective and nonselective beta‐blockers on survival in patients with ovarian cancer

   2015 · 196 citations

8. National Estimates of Gender-Affirming Surgery in the US

   2023 · 187 citations

9. Survival outcome prediction in cervical cancer: Cox models vs deep-learning model

   2018 · 179 citations

10. Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study

    2020 · 175 citations

11. Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment

    2013 · 160 citations

12. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy

    2009 · 156 citations

13. Genomics to immunotherapy of ovarian clear cell carcinoma: Unique opportunities for management

    2018 · 143 citations

14. Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma.

    2019 · 142 citations

15. Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm

    2020 · 140 citations

16. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO–JSOG joint study

    2019 · 138 citations

17. Overcoming platinum resistance in ovarian carcinoma

    2010 · 134 citations

18. Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer

    2019 · 121 citations

19. Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity

    2020 · 117 citations

20. Prefrontal gray matter increases in healthy individuals after lithium treatment: A voxel-based morphometry study

    2007 · 116 citations

21. Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma

    2016 · 111 citations

22. Impact of histological subtype on survival of patients with surgically-treated stage IA2–IIB cervical cancer: Adenocarcinoma versus squamous cell carcinoma

    2012 · 110 citations

23. Hypofrontality and microvascular dysregulation in remitted late-onset depression assessed by functional near-infrared spectroscopy

    2005 · 110 citations

24. Biological Roles of the Delta Family Notch Ligand Dll4 in Tumor and Endothelial Cells in Ovarian Cancer

    2011 · 108 citations

25. Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth

    2014 · 104 citations

← Return to the university profile